Article Text

Download PDFPDF
Child death review processes in paediatric intensive care units: a national survey of practice against statutory and operational guidance
  1. James Fraser1,
  2. Miriam R Fine-Goulden2,
  3. Adam Nicholls3,
  4. Thomas Main1,
  5. Pascale du Pré4,
  6. Sarah Box1,
  7. Alvin Schadenberg1,
  8. Anjalika Mallick4,
  9. Omer Aziz1
  1. 1 Paediatric Intensive Care Unit, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK
  2. 2 Paediatric Intensive Care, Evelina London Children’s Hospital, London, UK
  3. 3 Paediatric Intensive Care Unit, Royal Manchester Children’s Hospital, Manchester, UK
  4. 4 Paediatric Intensive Care Unit, Great Ormond Street Hospital For Children NHS Foundation Trust, London, UK
  1. Correspondence to Dr Omer Aziz; omer.aziz{at}uhbw.nhs.uk

Abstract

In 2018, Her Majesty's Government published statutory and operational guidance setting out how children’s deaths are reviewed in England, aiming to ensure practice is standardised and review of each child’s death is of uniform quality.

Objective A national survey of paediatric intensive care units (PICUs) to review the implementation of the statutory guidance.

Design Online survey exploring child death review (CDR) practices against expected operational standards across three domains: (1) Logistics and administration of the CDR process, (2) the CDR meeting and (3) communication with bereaved families.

Results 19/21 (91%) English PICUs, 1/1 Welsh and 1/1 Northern Irish PICUs responded to the survey request. 6/21 PICUs reported no remuneration for their CDR work. 18/21 reported routinely notifying the local child death overview panel of a child death within 48 hours as per statutory guidance. 8/21 (38%) achieved the current National Health Service England quality outcome target of holding the CDR meeting within 3 months of a child’s death. 17/21 (81%) PICUs appointed a ‘key worker’ as a single point of access to bereaved families. 12/21 (52%) PICUs routinely offered families the option to be informed of the outcome of the CDR meeting at bereavement follow-up.

Conclusions This survey is the first to report on CDR practices in PICUs. It highlights significant variation between units in the application of national guidance. It suggests that further recommendations are required in the application of the statutory guidance to ensure greater parity between units, that learning is shared effectively between agencies and that all bereaved families receive the appropriate information and support.

  • Intensive Care Units, Paediatric
  • Paediatrics
  • Mortality

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

View Full Text

Footnotes

  • X @finegoulden

  • Contributors OA, JF and AS equally contributed to the design and conduct of the survey. JF, MFG, AN, TM, PdP, SB, AS, AM and OA contributed to writing of the manuscript. OA is the guarantor for this manuscript and accepts full responsibility for the finished work and the conduct of the study and had access to the data and controlled the decision to publish.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Supplemental material This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.